(Press-News.org) SAN FRANCISCO, April 3, 2015 -- A potent risk factor for developing major depressive disorder (MDD) during fertility treatment is something health providers are likely not even looking for, according to new research from San Francisco State University.
Fertility treatment patients and their partners are far more likely to experience MDD than the general population, the study found, and a key factor in predicting a patient's risk is whether he or she has a previous diagnosis of major depression. But past history is something that fertility treatment providers may not routinely screen for, said Sarah Holley, an assistant professor of psychology at SF State and lead author of the study.
"The things that are typically assessed, such as whether you are feeling down or anxious when treatment begins, can be really useful information, but our research shows that a past history of MDD is actually a stronger indicator of whether a fertility patient will develop MDD during treatment," said Holley. "This suggests it would be useful to include an assessment of a history of MDD as part of a pre-treatment screener."
Screening for previous episodes of MDD, Holley added, would allow a provider to refer those most at risk for major depression during treatment for further counseling or support so they may receive whatever additional help they need during treatment.
Researchers and mental health treatment providers have known that MDD is a recurring disease and that it is likely to occur during stressful life events such as fertility treatment. But this study is the first to capture the actual rate of MDD among fertility patients in the United States, as well as point to a patient's history as the key indicator of recurrence. The research will be published in the May issue of the journal Fertility and Sterility.
To be diagnosed with MDD, an individual must, for a two-week period, experience a depressed mood or pervasive loss of interest or pleasure, plus four other symptom criteria such as disturbances in sleep or appetite, feelings of worthlessness or guilt, indecision or suicidal ideation. MDD itself can lead to withdrawal, isolation from friends and family and lost work, and is a major risk factor for suicide.
"Qualifying for MDD is more serious than experiencing low mood or crying a lot, which are some of the things that go into the type of standard depression inventories given to patients," Holley said. "It's a really debilitating disorder, and actually one of the leading causes of disability in this country."
Researchers surveyed 174 women and 144 male partners who had unsuccessfully gone through fertility treatment and found that 39.1 percent of the women and 15.3 percent of the men met the criteria for MDD during the 18-month course of the study, compared with the U.S. annual prevalence rate for MDD of 8.4 percent of women and 5.2 percent of men. The results indicate that, even accounting for the 18-month time period of the study, fertility treatment patients suffer from notably high rates of MDD. In addition, Holley and her colleagues compared a patient's past history of MDD with other well-established risk factors -- such as baseline levels of depression and anxiety symptoms, as well as partner support -- and found it was a stronger predictor of whether patients and partners ultimately developed MDD during fertility treatment than these more commonly screened-for indicators.
"People often describe fertility treatment as one of the most distressing things they've ever experienced," Holley said. "It's a prolonged process filled with uncertainty, and often it is very expensive. It can be very physically demanding, especially for women. It can have a profound effect on a couple's relationship."
Understanding risk for MDD during fertility treatment is important for a number of reasons, she added. First, MDD can lead to a couple dropping out of fertility treatment altogether. Second, if treatment is ultimately successful, MDD during treatment potentially spill over into the prenatal or post-partum periods.
"Helping patients and partners either before the depression takes hold, or being able to identify it and treat it as soon as possible, has the potential to help them through the very stressful process of treatment and possibly beyond," she said.
Future research will look at the experiences of same-sex couples during fertility treatment to assess rates of MDD, and examine whether the risk factors for MDD during fertility treatment vary for sexual minority patients and partners compared with their heterosexual counterparts.
INFORMATION:
"Prevalence and predictors of major depressive disorder for fertility treatment patients and their partners" by Sarah R. Holley, Lauri A. Pasch, Maria E. Bleil, Steve Gregorich, Patricia Katz and Nancy Adler will be published in the May issue of the journal Fertility and Sterility and is available online via ScienceDirect at http://www.sciencedirect.com/science/article/pii/S0015028215001405
An experiment conducted by Princeton researchers has revealed an unlikely behavior in a class of materials called frustrated magnets, addressing a long-debated question about the nature of these discontented quantum materials.
The work represents a surprising discovery that down the road may suggest new research directions for advanced electronics. Published this week in the journal Science, the study also someday may help clarify the mechanism of high-temperature superconductivity, the frictionless transmission of electricity.
The researchers tested the frustrated ...
Like most other plants, rice is well equipped with an effective immune system that enables it to detect and fend off disease-causing microbes. But that built-in immunity can be further boosted when the rice plant receives a receptor protein from a completely different plant species, suggests a new study led by UC Davis plant-disease experts.
The study findings, which may help increase health and productivity of rice, the staple food for half of the world's population, are reported online in the journal PLOS Pathogens at http://bit.ly/1GJBEQZ.
"Our results demonstrate ...
Genetic studies in humans, zebrafish and mice have revealed how two different types of genetic variations team up to cause a rare condition called Hirschsprung's disease. The findings add to an increasingly clear picture of how flaws in early nerve development lead to poor colon function, which must often be surgically corrected. The study also provides a window into normal nerve development and the genes that direct it.
The results appear in the April 2 issue of the American Journal of Human Genetics.
About one in every 5,000 babies is born with Hirschsprung's disease, ...
CANCER RESEARCH UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to research published in Cancer Cell today (Thursday)*.
The team, from the Cancer Research UK Centre at the UCL (University College London) Cancer Institute, found that mutations in the KRAS gene interferes with protective self-destruct switches, known as TRAIL receptors, which usually help to kill potentially cancerous cells.
The research, carried out in cancer cells and mice, shows ...
Brazilian researchers at D'OR Institute for Research and Education (IDOR) and Federal University of Rio de Janeiro (UFRJ) have taken what they describe as an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson's disease. Using an FDA approved substance for treating stomach cancer, Rehen and colleagues were able to grow dopamine-producing neurons derived from embryonic stem cells that remained healthy and functional for as long as 15 months after implantation into mice, restoring motor function without forming tumors.
Parkinson's, ...
PROVIDENCE, R.I. - Adam C. Levine, M.D., an emergency medicine physician at Rhode Island Hospital and The Miriam Hospital who treated Ebola-infected patients in Liberia last year, used his field experience to create a tool to determine the likelihood that patients presenting with Ebola symptoms will actually carry the virus. His research was published in the Annals of Emergency Medicine today.
Ebola Virus Disease (EVD) has affected 24,000 persons during the current epidemic, which is the largest recorded outbreak of EVD in history. Over 10,000 people have died in West ...
Scientists use small molecule that suppresses cancer-causing genes in glioblastoma
Nanotechnology crosses blood-brain barrier to reach tumor cells
Approach has potential to silence genes in other cancers and genetic diseases
CHICAGO --- Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.
While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method stops the source ...
ROCHESTER, Minn. -- Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease.
A Mayo Clinic-led team of international researchers has now combined 77 of these common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer. This factor, known as a polygenic risk score, was built from the genetic data of more than 67,000 ...
If a time machine was available, would it be right to kill Adolf Hitler when he was still a young Austrian artist to prevent World War II and save millions of lives? Should a police officer torture an alleged bomber to find hidden explosives that could kill many people at a local cafe? When faced with such dilemmas, men are typically more willing to accept harmful actions for the sake of the greater good than women. For example, women would be less likely to support the killing of a young Hitler or torturing a bombing suspect, even if doing so would ultimately save more ...
HOUGHTON, Mich. (April 3, 2015): Central Appalachian forests have been experiencing the effects of a changing climate for decades, and effects such as more heavy rainfall events, more drought, and more hot days are likely to continue, according to a new vulnerability assessment for the region by the U.S. Forest Service and many partners.
The assessment describes effects of climate change that have already been observed, projected changes in the climate and the landscape, and forest vulnerabilities for nine forest ecosystem types in a 29-million-acre area of Ohio, West ...
